At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 34 enrolled
Drug / intervention
Zoledronic acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-blind, Placebo Controlled Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly Compared to Placebo in Osteoporotic Children Treated With Glucocorticoids.
In Brief
A Phase 3 clinical trial evaluating Zoledronic acid and Placebo for Osteoporosis. Completed, enrolled 34 participants across 12 sites in 6 countries.
Detailed Summary
This study was designed to evaluate the efficacy and safety of zoledronic acid compared to placebo in osteoporotic children treated with glucocorticoids
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoporosis
CountriesAustralia, Canada, Hungary, Russia, South Africa, United Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2008
Enrollment StartDec 2008
Primary CompletionMar 2018
TodayJul 2026
First PostedNov 27, 2008
Enrollment StartDec 4, 2008
Primary CompletionMar 5, 2018
TodayJul 2, 2026
Enrollment to primary: 9.3 yearsPosted 17.6 years ago
Interventions
Zoledronic aciddrug
intravenous infusion
Placebodrug
intravenous infusion